MRK vs. ABBV
Compare and contrast key facts about Merck & Co., Inc. (MRK) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: MRK or ABBV.
Correlation
The correlation between MRK and ABBV is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
MRK vs. ABBV - Performance Comparison
Key characteristics
MRK:
-1.38
ABBV:
0.42
MRK:
-1.86
ABBV:
0.70
MRK:
0.75
ABBV:
1.11
MRK:
-0.86
ABBV:
0.55
MRK:
-1.65
ABBV:
1.37
MRK:
21.30%
ABBV:
8.28%
MRK:
25.66%
ABBV:
27.03%
MRK:
-68.62%
ABBV:
-45.09%
MRK:
-38.54%
ABBV:
-15.98%
Fundamentals
MRK:
$198.72B
ABBV:
$313.20B
MRK:
$6.74
ABBV:
$2.39
MRK:
11.68
ABBV:
74.08
MRK:
0.72
ABBV:
0.38
MRK:
3.10
ABBV:
5.56
MRK:
4.28
ABBV:
92.46
MRK:
$48.39B
ABBV:
$44.02B
MRK:
$39.64B
ABBV:
$33.24B
MRK:
$19.98B
ABBV:
$12.60B
Returns By Period
In the year-to-date period, MRK achieves a -19.05% return, which is significantly lower than ABBV's 3.41% return. Over the past 10 years, MRK has underperformed ABBV with an annualized return of 7.14%, while ABBV has yielded a comparatively higher 15.49% annualized return.
MRK
-19.05%
-9.14%
-23.33%
-35.27%
3.69%
7.14%
ABBV
3.41%
-9.59%
-3.11%
11.40%
21.58%
15.49%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
MRK vs. ABBV — Risk-Adjusted Performance Rank
MRK
ABBV
MRK vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
MRK vs. ABBV - Dividend Comparison
MRK's dividend yield for the trailing twelve months is around 3.96%, more than ABBV's 3.54% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRK Merck & Co., Inc. | 3.96% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% | 3.12% |
ABBV AbbVie Inc. | 3.54% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
MRK vs. ABBV - Drawdown Comparison
The maximum MRK drawdown since its inception was -68.62%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for MRK and ABBV. For additional features, visit the drawdowns tool.
Volatility
MRK vs. ABBV - Volatility Comparison
The current volatility for Merck & Co., Inc. (MRK) is 10.96%, while AbbVie Inc. (ABBV) has a volatility of 12.34%. This indicates that MRK experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
MRK vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Merck & Co., Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities